Articles

Poll

Podcasts

Slideshows

Videos

At SLEEP 2025, Sachdeva outlined evolving liability concerns, transparency issues, and steps clinicians can take to safely integrate AI in practice.

Mitigating AI Legal Risks in Sleep Medicine, With Ramesh Sachdeva, MD, PhD

​​At SLEEP 2025, Levine highlighted how the Syn-One skin test detects early signs of Parkinson Disease in patients with iRBD with the observation of phosphorylated alpha-synuclein.

Skin Test Detects Neurodegeneration Risk in 75% of iRBD Cases, With Todd Levine, MD

In this Q&A, Narcisse shared what the association between greater oral microbiome diversity and longer sleep in teens and young adults could mean for early-life disease prevention.

Oral Microbiome Diversity Links to Longer Sleep, With Marie-Rachelle Narcisse, PhD

At SLEEP 2025, Sachdeva discussed the evolving legal implications of AI use in sleep medicine, including clinician liability, informed consent, and responsible integration into care.

Legal Gray Areas of AI in Sleep Medicine, With Ramesh Sachdeva, MD, PhD

At SLEEP 2025, HCPLive spoke with Narcisse about NHANES-based findings suggesting longer sleep duration is associated with richer and more diverse oral microbiomes.

Longer Sleep Tied to Oral Microbiome Diversity in Teens, With Marie-Rachelle Narcisse, PhD

At SLEEP 2025, Malhotra emphasized the need for weight loss to resolve obesity hypoventilation syndrome and highlighted limitations of current therapies.


Weight Loss May Be Key to Resolving OHS, Says Atul Malhotra, MD 

At SLEEP 2025, Malhotra shared updates on diagnosing and managing OHS, including the role of bicarbonate, PAP use, and weight loss.

Updates in Obesity Hypoventilation Syndrome Diagnosis, with Atul Malhotra, MD

A study presented at SLEEP 2025 found longer and more variable napping patterns are associated with increased all-cause mortality in middle-to-older aged adults.


Naps at Noon Linked to Mortality Risk in Older Adults, with Chenlu Gao, PhD

At SLEEP 2025, HCPLive spoke to Strollo about the phase 3 SynAIRgy trial which evaluated AD109, a first-in-class, once-daily oral neuromuscular modulator, for OSA.

AD109 Improves OSA in Phase 3 SynAIRgy Trial, With Patrick Strollo, MD

At SLEEP 2025, Cassiere discussed how pulse oximetry inaccuracies among patients with darker skin tones may lead to underdiagnosis or misclassification of sleep apnea severity.

Racial Bias in Pulse Oximetry Skews Sleep Apnea Diagnoses, Warns Hugh Cassiere, MD

Obstructive Sleep Apnea

Insomnia

The HCPLive insomnia page is a comprehensive resource for clinical news and insights on sleeplessness. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for insomnia, and more.

On the HCPLive sleep page, resources on the topics of medical news and expert insight into sleep medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on sleep apnea, insomnia, narcolepsy, and more.